Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2012
|
| gptkbp:ATCCode |
gptkb:B03XA04
|
| gptkbp:FDAWithdrawalDate |
2013
|
| gptkbp:genericName |
gptkb:peginesatide
|
| https://www.w3.org/2000/01/rdf-schema#label |
Omontys
|
| gptkbp:indication |
anemia in chronic kidney disease
|
| gptkbp:legalStatus |
withdrawn
|
| gptkbp:manufacturer |
gptkb:Takeda
gptkb:Affymax |
| gptkbp:mechanismOfAction |
erythropoiesis-stimulating agent
|
| gptkbp:retired |
serious hypersensitivity reactions
|
| gptkbp:routeOfAdministration |
subcutaneous
intravenous |
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|